PTPRC and neoplasm: In addition, it has been reported that CD45 is the receptor of CD24D, and the immunomodulatory peptide CD24D can reverse the immunosuppression induced by TNBC by activating the CD45 signaling pathway, and participate in the biological process of immunomodulatory tumor cell killing.